Not an SEC registrant

Allergan, Inc.

Customers

None disclosed

Suppliers

0 disclosed

Latest period

Dec 31, 2020

10-K filed 2021-03-24

Suppliers 2

Companies that disclose Allergan, Inc. as a major customer, as a share of their own revenue. 0 active, 2 lapsed.

Company	% of their revenue	Est. $ from Allergan, Inc.	Period	Trend	Status	Source
Aptinyx Inc. Aptinyx Inc.	100%	$1.6M	FY 2020-12-31	±0.0pp	Lapsed Last seen 2020-12-31	10-K 2021-03-24
During the years ended December 31, 2020 and 2019, one research collaborator, Allergan plc (“Allergan”) represented 100% of the Company’s revenues (see Note 4). 10-K filed 2021-03-24 Period FY 2020-01-01 to 2020-12-31 (100%), FY 2019-01-01 to 2019-12-31 (100%)Accession 0001558370-21-003428
AMPH Amphastar Pharmaceuticals, Inc.	22%	$13.1M	3M 2016-03-31	±0.0pp	Lapsed Last seen 2016-03-31	10-Q 2016-05-10
Allergan plc (1) 14 % 12 % 22 % 23 % 10-Q filed 2016-05-10 Period 3M 2016-01-01 to 2016-03-31 (22%), 3M 2015-01-01 to 2015-03-31 (23%)Accession 0001558370-16-005745 Allergan plc (1) 21 % 30 % 35 % 10-K filed 2016-03-15 Period FY 2015-01-01 to 2015-12-31 (21%)Accession 0001558370-16-004146 Allergan plc (1) 17 % 18 % 22 % 35 % 22 % 33 % 10-Q filed 2015-11-13 Period 3M 2015-07-01 to 2015-09-30 (22%), 3M 2014-07-01 to 2014-09-30 (35%)Accession 0001558370-15-002652 Allergan plc (1) 24 % 18 % 21 % 35 % 22 % 33 % 10-Q filed 2015-08-13 Period 3M 2015-04-01 to 2015-06-30 (21%)Accession 0001171843-15-004674

Get an email when Allergan, Inc.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.